ECLEcolab
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.4 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +7% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 16.9% now against 18.3% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is ECL growing?
Ecolab has grown revenue 4.5% a year over three years and 6.8% a year over five, with earnings per share compounding at 22%.
Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +6.8%
Revenue growth, 5-year rate · +4.5% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- +22%
Earnings per share, 3-year rate · revenue +4.5% · earnings outgrew revenue: margins or the share count worked for shareholders
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $12.7B
- Revenue FY2022
- $14.2B
- Revenue FY2023
- $15.3B
- Revenue FY2024
- $15.7B
- Revenue FY2025
- $16.1B
Annual income statements as filed with the SEC.
Specialty Chemicals
The closest names by size in the same industry